Dillon & Associates’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-3,715
Closed -$215K 79
2023
Q3
$215K Sell
3,715
-75
-2% -$4.34K 0.04% 76
2023
Q2
$243K Sell
3,790
-15
-0.4% -$962 0.04% 74
2023
Q1
$263K Hold
3,805
0.05% 72
2022
Q4
$274K Sell
3,805
-150
-4% -$10.8K 0.06% 67
2022
Q3
$281K Hold
3,955
0.07% 64
2022
Q2
$305K Hold
3,955
0.07% 62
2022
Q1
$289K Hold
3,955
0.05% 63
2021
Q4
$245K Sell
3,955
-463
-10% -$28.7K 0.04% 69
2021
Q3
$261K Sell
4,418
-9
-0.2% -$532 0.05% 63
2021
Q2
$297K Sell
4,427
-1,180
-21% -$79.2K 0.06% 61
2021
Q1
$353K Sell
5,607
-51
-0.9% -$3.21K 0.08% 59
2020
Q4
$351K Buy
5,658
+51
+0.9% +$3.16K 0.08% 56
2020
Q3
$336K Sell
5,607
-77
-1% -$4.61K 0.08% 55
2020
Q2
$335K Hold
5,684
0.09% 56
2020
Q1
$318K Hold
5,684
0.11% 55
2019
Q4
$364K Buy
+5,684
New +$364K 0.1% 56
2019
Q1
Sell
-4,090
Closed -$213K 67
2018
Q4
$213K Sell
4,090
-1,150
-22% -$59.9K 0.08% 62
2018
Q3
$325K Sell
5,240
-515
-9% -$31.9K 0.11% 59
2018
Q2
$317K Buy
5,755
+1,000
+21% +$55.1K 0.12% 59
2018
Q1
$300K Sell
4,755
-10
-0.2% -$631 0.12% 60
2017
Q4
$291K Buy
4,765
+540
+13% +$33K 0.11% 61
2017
Q3
$270K Hold
4,225
0.11% 61
2017
Q2
$237K Hold
4,225
0.1% 67
2017
Q1
$228K Buy
4,225
+275
+7% +$14.8K 0.1% 67
2016
Q4
$229K Buy
+3,950
New +$229K 0.1% 66